Abnormalities in lipoprotein metabolism in hemodialysis pa-
mained the most commonly reported cause of death.
tients.
Multiple factors contribute to the atherosclerotic pro-Background. Patients on chronic hemodialysis treatment cess, but dyslipidemia, which is frequently found in paare at elevated atherogenic risk, and dyslipidemia appears to be tients on HD, is one of the key factors in the initiation one of the major risk factors. However, most of these patients and acceleration of atherosclerosis. Lipoprotein metaboexhibit elevated serum triglycerides, whereas serum cholesterol and low-density lipoprotein (LDL) cholesterol levels are in the lism is influenced by many determinants as the dialysis normal range. This study was therefore designed to examine treatment itself, the use of heparin as anticoagulant, the the influence of hypertriglyceridemia under the condition of membrane material, and the underlying uremia [1] . An hemodialysis and diabetes mellitus on LDL metabolism. atherogenic and typical lipoprotein profile can be de- Abbreviations are: CO, controls (N ϭ 10); HD, hemodialysis patients (N ϭ 10); NIDDM-HD, hemodialysis patients with type 2 diabetes mellitus (N ϭ 10); Chol, cholesterol; TG, triglycerides. Data are given as mean Ϯ sem. a P Ͻ 0.05 versus controls time and diene formation [5] were measured to determine susceptibility to oxididation of the different LDL preparations. Uptake kinetics were performed with HepG2 cells and mouse peritoneal macrophages by the method of Goldstein, Basu, and Brown [6] .
RESULTS
In our HD patients, elevated serum triglycerides and triglyceride enrichment of VLDL and LDL were consistent findings. This was most pronounced in patients with diabetes mellitus. In contrast, total cholesterol levels were only slightly elevated ( Table 1) . Subfractionation of LDL revealed that hypertriglyceridemia was associated with an atherogenic LDL subfraction pattern. The increase in LDL triglycerides was due to an accumulation of a triglyceride-rich large, buoyant fraction (LDL-1, density range, 1019 to 1031 kg/liter) and a small dense To identify modifications of LDL that may additionally reduce uptake via LDL receptor, especially in dia-DISCUSSION betic patients, we measured the degree of glycation of apo B of LDL and found elevated concentrations in the Hypertriglyceridemia, especially in combination with diabetic patients (HD, 2.6 Ϯ 0.4%; NIDDM-HD, 4.7 Ϯ diabetes mellitus, contributes to the elevated cardiovas-1.6% vs. CO, 2.5 Ϯ 0.4%, P Ͻ 0.05). Significant changes cular risk of HD patients. In this study, LDL, isolated in lag time or diene formation could not be detected, from hypertriglyceridemic nondiabetic and diabetic HD but lipid peroxides in LDL were significantly elevated, patients, exhibited impaired receptor specific uptake via especially in diabetic patients with higher concentrations the LDL receptor of HepG2 cells. LDL degradation was of glycated apo B (HD, 0.058 Ϯ 0.028; NIDDM-HD, even more reduced if hypertriglyceridemia was aggra-0.158 Ϯ 0.126 vs. CO, 0.027 Ϯ 0.016 mol/100 g LDL vated by coexisting diabetes mellitus. protein, P Ͻ 0.05). Binding experiments with 125 I-labeled
In HD treatment and diabetes mellitus, a number of LDL in HepG2 cells (Fig. 1) showed that these modified conditions are present, which may account for dimin-LDL were taken up by the LDL receptor of HepG2 cells ished cellular LDL metabolism: Independent of the etiolwith lower affinity than control LDL but were enhanced ogy, hypertriglyceridemia leads to prominent compositaken up by scavenger receptors of macrophages. This tional and configurational changes of LDL particles [7] . was most pronounced for LDL of hypertriglyceridemic Triglyceride-rich LDLs are smaller and denser particles than control LDLs, and the alteration in the lipid-protein diabetic patients.
